Blog
RSS FeedPosted by Michael Wonder on 16 Jun 2021
Emmaus Life Sciences announces submission of marketing authorisation application to Swissmedic; Ideogen to manage early access program
15 June 2021 - Emmaus Life Sciences anounced today it has received confirmation from the Swiss Agency for Therapeutic Products ...
Posted by Michael Wonder on 06 Jan 2021
MorphoSys and Incyte announce the acceptance of the Swissmedic marketing authorisation application for tafasitamab
5 January 2021 - The Swissmedic marketing authorisation application seeks approval for tafasitamab in combination with lenalidomide for the treatment ...
Posted by Michael Wonder on 21 Dec 2020
Swissmedic approves Buvidal for the treatment of opioid dependence
18 December 2020 - Camurus announced today that the Swiss agency for therapeutic products, Swissmedic, has approved weekly and monthly Buvidal ...
Posted by Michael Wonder on 10 Dec 2020
Switzerland ramps up COVID-19 vaccine order
9 December 2020 - Switzerland has increased its coronavirus vaccine order with Moderna by three million doses. ...
Posted by Michael Wonder on 22 Aug 2020
Swissmedic approval times slow down
20 August 2020 - Swissmedic took 4% longer to process each new application for a new active substance (NA NAS) ...
Posted by Michael Wonder on 20 Aug 2020
Swiss data protection chief pushes back on drug pricing secrecy
20 August 2020 - A proposed change to the new health insurance law that seeks to keep drug prices under lock ...
Posted by Michael Wonder on 13 Aug 2020
Drug prices fall in Switzerland but generics remain expensive
13 August 2020 - Switzerland is narrowing the gap with other European countries when it comes to the cost of medicines. ...
Posted by Michael Wonder on 21 Jul 2020
PharmaMar has filed lurbinectedin for Temporary Marketing Authorisation with the Swiss Agency for Therapeutic Products
20 July 2020 - The filing is based on the Phase II multi-centre basket trial efficacy data. ...
Posted by Michael Wonder on 05 Jul 2020
Switzerland fast-tracks anti-viral medication against COVID-19
2 July 2020 - Swissmedic, the agency that oversees the use of medicaments in Switzerland, took days to fast-track approval ...
Posted by Michael Wonder on 14 May 2020
Swissmedic approves Carbetocin Ferring for the prevention of postpartum haemorrhage in all births
13 May 2020 - Carbetocin Ferring is the first medicine approved under the new Swissmedic and Marketing Authorisation for Global Health ...
Posted by Michael Wonder on 13 May 2020
Seattle Genetics announces the approval of Tukysa (tucatinib) in Switzerland for the treatment of patients with metastatic HER2-positive breast cancer
12 May 2020 - First approval for Tukysa outside of the U.S. ...
Posted by Michael Wonder on 21 Apr 2020
Swiss deal on cystic fibrosis drugs could change price negotiations
21 April 2020 - The deal is expected to help 400 eligible cystic fibrosis patients in Switzerland. ...
Posted by Michael Wonder on 07 Apr 2020
Novartis announces first European donation of hydroxychloroquine to Switzerland
3 April 2020 - Novartis has committed to making a global donation of up to 130 million doses of the anti-malarial ...
Posted by Michael Wonder on 04 Apr 2020
Swiss Government expands powers to force firms to make supplies to fight COVID-19
3 April 2020 - The Swiss government on Friday boosted its powers to order companies to raise production of critical ...
Posted by Michael Wonder on 13 Nov 2019
FDA’s Project Orbis may expand to Singapore and Switzerland
12 November 2019 - The US FDA may expand a pilot project that allows for simultaneous drug approval decisions from ...